Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
ConclusionsAmong CHB patients under antiviral therapy showing suppressed HBV replication, low CAP value predicted higher risk for HCC among ACLD patients, indicating that CAP value has a prognostic implication in this population.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Infectious Diseases | Liver | Liver Cancer | Liver Disease | Urology & Nephrology | Virology